한스바이오메드

042520KOSDAQ

48.1 / 100

Reference Date: 2026-09-08

Financial Score12.5 / 40

News Sentiment19.6 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 9.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HansBioMed, established in 1999, develops, manufactures, and sells skin and bone tissue implants and medical devices. Its key products, Bella Cell HD and SureFuse, account for approximately 61% of sales, with global expansion through overseas subsidiaries in the U.S., Thailand, and the U.K. The company continues to invest in R&D for regenerative medicine and new medical technologies.

Number of Employees

289people

Average Salary

41.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

8.25Industry Average 1.200.0Point

6.9x industry avg (risky)

ROE

-63.51Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

33.90Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲7.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼2061.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -42.1% (declining, 3yr)

Detailed News Sentiment

7 totalPositive 6Neutral 1Negative 0Average Sentiment Score 78.6

Positive
한스바이오메드, 유방 재건용 '바운스' 3차병원 공급 확대…"환자 선....
한스바이오메드의 유방 재건용 '바운스' 공급 확대 계획 발표로 인해 시장 진출 확대 기대감 증가.
Positive
한스바이오메드, 가슴보형물 ‘바운스’ 상급종합병원 공급 확대 나서
한스바이오메드의 국산 가슴보형물 '바운스'가 서울아산병원 등 주요 상급종합병원으로의 공급 확대를 통해 시장 점유율 증가 기대.
Positive
한스바이오메드 ‘셀르디엠’, 의료기관 거래처 1,000곳 돌파… 휴젤....
한스바이오메드의 셀르디엠이 휴젤과의 협업으로 의료기관 거래처를 1,000곳 이상 확보하며 시장 확장에 성공했다.

Detailed Momentum

52-week position3.0Point

52w lower range (23%)

Current 19,600Won52-week high 55,70052-week low 8,250

1-month return1.0Point

1m -9.47% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral주식등의대량보유상황보고서(약식)2026-09-03
Neutral주식등의대량보유상황보고서(약식)2026-09-02
Neutral분기보고서 (2026.06)2026-08-13
Neutral기업설명회(IR)개최2026-08-10